SEC Comment Letter 0000000000-24-012881 to BullFrog AI Holdings, Inc. (BFRG)
BullFrog AI Holdings, Inc.
Date: Nov. 20, 2024 · CIK: 0001829247 · Accession: 0000000000-24-012881
AI Filing Summary & Sentiment
File numbers found in text: 333-283105
Show Raw Text
November 20, 2024
Vininder Singh
Chief Executive Officer
BullFrog AI Holdings, Inc.
325 Ellington Blvd., Unit 317
Gaithersburg, MD 20878
Re:BullFrog AI Holdings, Inc.
Registration Statement on Form S-1
Filed November 8, 2024
File No. 333-283105
Dear Vininder Singh:
We have conducted a limited review of your registration statement and have the
following comment.
Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe the comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments.
Registration Statement on Form S-1 Filed November 8, 2024
Management's Discussion and Analysis of Financial Condition..., page 43
1.Please revise this section to include, in addition to the discussion of the interim
periods presented, a discussion of the financial condition, changes in financial
condition, and results of operations for the fiscal years ended December 31, 2023 and
2022. Refer to Item 303(b) of Regulation S-K and Instruction 1 thereto.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff.
November 20, 2024
Page 2
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
Please contact Jessica Dickerson at 202-551-8013 or Joe McCann at 202-551-6262
with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Arthur S. Marcus, Esq.